WhatsApp USA: +1 6032769350 | WhatsApp HK: +852 63697831
Global Healthcare Medical
GHM Rhinovirus (RHV) Antigen Rapid Test US – Qualitative Detection of Rhinovirus Antigen with 15-Minute Results, Nasopharyngeal Swab Sample Compatibility, and Professional Point-of-Care Use
GHM Rhinovirus (RHV) Antigen Rapid Test US – Qualitative Detection of Rhinovirus Antigen with 15-Minute Results, Nasopharyngeal Swab Sample Compatibility, and Professional Point-of-Care Use
SKU: GHM Rhinovirus (RHV) Antigen Rapid Test US
Brand: Global Healthcare Medical
Product Overview
Global Healthcare Medical GHM Rhinovirus (RHV) Antigen Rapid Test US is a lateral flow immunochromatographic assay designed for the qualitative detection of rhinovirus antigen directly from human nasopharyngeal swab specimens. The kit is intended for use by healthcare professionals as an aid in the diagnosis of rhinovirus respiratory infection in symptomatic individuals.
Human rhinovirus (HRV) is a member of the Picornaviridae family and the genus Enterovirus. The HRVs are positive-sense, single-stranded-RNA viruses, and there are well over 100 serotypes generally organized into three species: HRV-A (74 serotypes), HRV-B (23 serotypes), and HRV-C (more than 50 serotypes identified to date). HRVs are responsible for over half of all common colds and have been increasingly associated with more severe upper and lower respiratory tract infections in children, the elderly, and the immunocompromised.
HRV infections occur worldwide with peak incidence in the early fall and spring in temperate climates, although infection can occur year round. Among 74,330 children and adolescents hospitalized for acute respiratory infections, HRV was detected in 18,681 cases (25.13%), exhibiting year-round prevalence with seasonal peaks in spring and autumn. HRV mono-infections are significantly correlated with hospitalizations for acute wheezing illnesses and more severe clinical outcomes. Co-infections occurred in 32.00% of HRV cases and were associated with higher rates of pneumonia and severe pneumonia. Clinical studies report that HRV infection is the second most frequently recognized agent associated with pneumonia and bronchiolitis in infants and young children, and HRV infection is associated with one-third to one-half of asthma exacerbations depending on age, linked to asthma hospitalizations in both adults and children.
The GHM Rhinovirus (RHV) Antigen Rapid Test US delivers qualitative results in just 15 minutes, supporting rapid clinical decision-making at the point of care. The test is compatible with nasopharyngeal swab specimens, providing a simple and efficient sample collection method suitable for a wide range of clinical settings.
The kit is intended for in vitro diagnostic use and professional use only, suitable for application scenarios including pediatric clinics, physician office laboratories, urgent care centers, emergency departments, hospital laboratories, and clinical laboratories. The VivaDiag product line is manufactured under an EN ISO 13485 certified quality management system covering in vitro diagnostic test kits and analyzers based on immunochromatography.
Key Features & Benefits
Colloidal Gold Immunochromatography – Reliable Qualitative Detection
The GHM Rhinovirus (RHV) Antigen Rapid Test US is based on lateral flow immunochromatography technology. The test strip contains colloidal gold-conjugated antibodies specific to rhinovirus antigens, along with immobilized capture antibodies on the test line. During testing, the extracted nasopharyngeal swab specimen reacts with the antibody-coated particles and migrates up the membrane to react with the antibodies on the membrane. A colored line is generated at the test line region if rhinovirus antigen is present in the specimen.
| Feature | Benefit |
|---|---|
| Colloidal gold immunochromatography | Established and reliable detection method |
| Rhinovirus-specific antibodies | Targeted detection of rhinovirus antigen |
| Qualitative visual result | Clear and interpretable test outcome |
| No equipment required | Simple and efficient testing workflow |
Fast Results – 15 Minutes
The GHM Rhinovirus (RHV) Antigen Rapid Test US provides qualitative results in just 15 minutes, supporting rapid clinical decision-making and efficient patient workflow in point-of-care settings.
| Feature | Benefit |
|---|---|
| 15-minute test time | Rapid turnaround for timely clinical decisions |
| Point-of-care compatibility | Suitable for pediatric clinics and physician offices |
| Efficient workflow | Enables immediate patient assessment |
| Quick sample-to-result | Supports high-throughput testing environments |
Nasopharyngeal Swab Sample Compatibility – Simple and Efficient Collection
The GHM Rhinovirus (RHV) Antigen Rapid Test US is compatible with human nasopharyngeal swab specimens, providing a simple and efficient sample collection method. The test is compatible with fresh respiratory specimens collected using sterile swabs.
| Feature | Benefit |
|---|---|
| Nasopharyngeal swab specimen | Simple and efficient sample collection |
| Compatible with standard sterile swabs | No special collection equipment required |
| Simple operation | Streamlined workflow in clinical settings |
| Patient-friendly | Comfortable sample collection experience |
Clinical Utility – Aid for Diagnosis of Rhinovirus Respiratory Infection
The GHM Rhinovirus (RHV) Antigen Rapid Test US is intended for use as an aid in the diagnosis of rhinovirus respiratory infection. Antigen testing is most effective during the acute phase of respiratory illness, when symptoms often resemble the common cold or other respiratory viral infections. The test provides rapid etiological diagnosis, enabling timely clinical decision-making and supporting infection control measures.
The test is particularly valuable for pediatric, geriatric, and immunocompromised patient populations, where rhinovirus infections are more prevalent and can be clinically severe. HRV is the most common respiratory virus detected in children and is strongly associated with acute wheezing illnesses and asthma exacerbations. Early identification of HRV infection supports appropriate clinical management, reduces unnecessary antibiotic use, and helps limit hospitalizations. In patients with asthma or COPD, detection of HRV infection can guide management of potential exacerbations.
| Feature | Benefit |
|---|---|
| Active infection detection aid | Supports identification of current rhinovirus infection |
| Early symptomatic phase utility | Optimized for the acute phase of respiratory infection |
| Differential diagnosis support | Helps distinguish rhinovirus from influenza, COVID-19, and other viral causes |
| Pediatric relevance | Particularly useful in pediatric clinical settings |
| Asthma and COPD relevance | Valuable for patients with underlying respiratory conditions |
| Infection control support | Enables prompt isolation and cohorting decisions |
| Clinical versatility | Useful across pediatric clinics, physician offices, and emergency settings |
High Accuracy – Trusted Clinical Performance
The GHM Rhinovirus (RHV) Antigen Rapid Test US is designed to deliver reliable clinical performance with high sensitivity and specificity. The test is calibrated to perform optimally in samples with high viral loads, where antigen rapid tests achieve their highest sensitivity.
| Parameter | Specification |
|---|---|
| Sensitivity | 92.31% |
| Specificity | 95.05% |
| Accuracy | 94.12% |
ISO 13485 Certified – Quality and Safety Compliance
The VivaDiag product line is manufactured under an EN ISO 13485 certified quality management system, demonstrating compliance with stringent international standards for the design, development, manufacture, and distribution of in vitro diagnostic test kits and analyzers.
| Feature | Benefit |
|---|---|
| EN ISO 13485 certification | Quality management system compliance |
| IVD scope | Certified for in vitro diagnostic test kits |
| Quality assurance | Meets high standards of quality and safety |
| Professional-grade | Designed for healthcare professional use |
CE Marked – European Conformity
The GHM Rhinovirus (RHV) Antigen Rapid Test US is CE marked for professional in vitro diagnostic use, demonstrating conformity with applicable European regulatory requirements for diagnostic medical devices.
| Feature | Benefit |
|---|---|
| CE marking | Regulatory compliance for professional use |
| Professional IVD use | Designed for trained healthcare personnel |
| Quality compliance | Meets European regulatory standards |
Product Specifications
| Specification | Detail |
|---|---|
| Model / SKU | GHM Rhinovirus (RHV) Antigen Rapid Test US |
| Product Code | IRHV-502 |
| Product Type | Rhinovirus (RHV) Antigen Rapid Test (Colloidal Gold) |
| Intended Use | Qualitative detection of rhinovirus antigen directly from human nasopharyngeal swab specimens; used as an aid in the diagnosis of rhinovirus respiratory infection |
| Detection Principle | Lateral flow immunochromatography; colloidal gold immunoassay |
| Target Antigen | Rhinovirus antigen |
| Specimen | Nasopharyngeal swab |
| Time to Result | 15 minutes |
| Sensitivity | 92.31% |
| Specificity | 95.05% |
| Accuracy | 94.12% |
| Storage Temperature | 2–30°C |
| Shelf Life | 24 months |
| Application Scenario | Pediatric clinic, physician office laboratory, urgent care center, emergency department, hospital laboratory, clinical laboratory, point-of-care |
| Regulatory Status | Manufactured under EN ISO 13485 certified quality management system; CE marked |
| Intended User | Professional healthcare use only |
| Kit Sizes | 20 tests/kit |
| Kit Contents | Rhinovirus Rapid Test Cassette, Extraction Buffer, Sterile Swabs, Instructions for Use |
Why Clinical Professionals Choose Global Healthcare Medical
| Consideration | GHM Rhinovirus (RHV) Antigen Rapid Test US |
|---|---|
| Colloidal gold immunochromatography | Established and reliable detection technology |
| 15-minute test time | Rapid turnaround for timely clinical decisions |
| Nasopharyngeal swab compatibility | Simple and efficient sample collection |
| Rhinovirus-specific detection | Targeted detection of rhinovirus antigen |
| High sensitivity and specificity | 92.31% sensitivity and 95.05% specificity |
| Asthma and COPD relevance | Valuable for patients with underlying respiratory conditions |
| Pediatric relevance | Particularly valuable in pediatric clinical settings |
| ISO 13485 certified | Quality management system compliance |
| CE marked | Regulatory compliance for professional use |
| Point-of-care compatible | Suitable for pediatric clinics, physician offices, and emergency departments |
About Global Healthcare Medical
Global Healthcare Medical is dedicated to connecting healthcare providers, retailers, and distributors with high-quality medical devices designed for reliable performance. The GHM Rhinovirus (RHV) Antigen Rapid Test US is part of our professional diagnostic line, developed to support accurate, efficient, and accessible point-of-care testing in clinical environments.
Our focus is on dependable performance, clear documentation, and responsive support for professional healthcare settings.
